Numerous scientific publications support the efficacy and safety of mesenchymal stem cells in the treatment of systemic diseases such as chronic renal failure or inflammatory bowel disease (IBD).
In recent years, the intravenous use of stem cells to treat numerous systemic and autoimmune pathologies has been investigated due to their immunomodulatory potential. However, there are still no stem cell-based medicine approved for this use.
Utilizamos cookies propias y de terceros con finalidad exclusivamente técnica. Más información
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.